Literature DB >> 21167145

Serum paraoxonase and arylesterase activities in patients with lacunar infarction: a case control study.

Ali Moghtaderi1, Mohammad Hashemi, Soroosh Dabiri, Abdolkarim Moazeni-Roodi, Motahreh Hosseini.   

Abstract

OBJECTIVES: The aim of this study was to assess paraoxonase (PON1) and arylesterase (ARE) activities and polymorphism in patients with lacunar infarctions. DESIGN AND METHODS: The PON1 activity, ARE and lipid profile were determined in 37 patients and 53 healthy individuals. Descriptive and inferential statistics were used to analyze the data.
RESULTS: A total of 37 patients (20 males and 17 females) were studied. The levels of PON1 activity in patients and healthy individuals were 63.5±46.7IU/L and 95.5±75.5IU/L, respectively (p=0.024). The same values for ARE were 54.3±19.3KU/L for patients and 69.1±29.3KU/L for controls (p=0.008). Polymorphism in Q192R location shows statistically different presentation in patient group compared to healthy controls with an odds ratio of 3.42 (CI 95%: 1.24-9.44, p=0.017).
CONCLUSIONS: According to this study, we suggest that PON1 192R polymorphism may play a minor role as a risk marker for developing lacunar infarctions in a group of Iranian population.
Copyright © 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167145     DOI: 10.1016/j.clinbiochem.2010.12.005

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  2 in total

1.  Association between PON1 L55M polymorphism and ischemic stroke: a systematic review and meta-analysis.

Authors:  Peng Shao; Da-Jun Qu; Rui-Ying Song; Ming-Lu Chen; Li-Hua Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis-Preliminary Data.

Authors:  Anna Baran; Anna Stepaniuk; Paulina Kiluk; Tomasz W Kaminski; Magdalena Maciaszek; Iwona Flisiak
Journal:  Metabolites       Date:  2022-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.